The Impact of the COVID-19 Pandemic and Lockdown on Mild Cognitive Impairment, Alzheimer's Disease and Dementia With Lewy Bodies in China: A 1-Year Follow-Up Study
Zhichao Chen(Capital Medical University), Yong Ji(Human Sciences Research Council), Jinghuan Gan(Capital Medical University), Yuchao Dou(Tianjin Huanhu Hospital), Jiuyan Han(Capital Medical University), Hao Wu(INTI International University), Min Fei(Yuncheng University), Shuai Liu(Tongji University), Xiaoshan Du(Tianjin Medical University), Xiaodan Wang(Center for Life Sciences), Peng Deng(Nankai University), Lingyun Ma(Capital Medical University), Han Zhu(Palo Alto University), Yaqi Yang(Northeast Agricultural University), Junying Xu(Wuxi People's Hospital)
Cited by 59
Related Papers
Data Resource Profile: The World Health Organization Study on global AGEing and adult health (SAGE)
|International Journal of Epidemiology|2012|775
The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
|Journal of Neuroinflammation|2018|268
A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementia
|Alzheimer s Research & Therapy|2021|200